Cetera Trust Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.5M Hold
2,087
1.26% 21
2026
Q1
$1.92M Hold
2,087
1.09% 27
2025
Q4
$2.24M Hold
2,087
1.2% 26
2025
Q3
$1.59M Hold
2,087
0.89% 34
2025
Q2
$1.63M Sell
2,087
-12
-0.6% -$9.32K 0.97% 32
2025
Q1
$1.73M Hold
2,099
1.1% 29
2024
Q4
$1.62M Hold
2,099
1.05% 31
2024
Q3
$1.86M Hold
2,099
1.14% 30
2024
Q2
$1.9M Hold
2,099
1.19% 29
2024
Q1
$1.63M Hold
2,099
0.98% 34
2023
Q4
$1.22M Buy
+2,099
New +$1.23M 0.76% 39

Other funds holding LLY

Cetera Trust Company's LLY Position: Q2 2026 in Review

Cetera Trust Company held its Eli Lilly (LLY) position steady in Q2 2026 at 2,087 shares worth $2.5M. The position accounts for 1.26% of the portfolio, ranked #21.

Cetera Trust Company first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cetera Trust Company held 2,087 shares of Eli Lilly worth $2.5M as of Q2 2026.
  • Cetera Trust Company left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 1.26% of Cetera Trust Company's portfolio in Q2 2026, its #21 holding.
  • Cetera Trust Company first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.